CDR132L

Antisense RNA medical therapy From Wikipedia, the free encyclopedia

CDR132L is an antisense RNA therapy that inhibits MiR-132. It is developed by Cardior Pharmaceuticals to treat heart failure.[1][2][3]

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.